Procedures & recovery · patient guide

Robotic Prostatectomy in China: Questions About Risks and Alternatives

A robotic prostatectomy removes the prostate for selected prostate cancers, with instruments controlled by the surgeon. No operation guarantees cancer control, continence or sexual function. Before deciding, ask the treating team in China how they weigh cancer control against functional priorities, what alternatives exist, and how catheter care, pathology review and follow-up are arranged.

Go to the practical guidance ↓
Illustrative image: A medical professional contemplates in a clinic room with anatomical models and books visible.
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

What the operation is and what it is not

Robotic-assisted radical prostatectomy is a way of removing the prostate gland. The surgical instruments are controlled by the surgeon rather than moving independently. The word robotic describes the tool, not a decision about whether surgery is the right choice for a particular cancer.

The operation is used for selected prostate cancers. Whether it is suitable for one patient depends on the cancer's characteristics, the patient's overall health and the priorities the patient brings to the decision. That assessment belongs to the treating urology team, not to a coordination service or an article.

A common misunderstanding is that robotic surgery removes risk. It does not. The relevant risks include effects on urinary control and sexual function, as well as the general risks of major surgery. The treating team should explain how these risks apply to the individual patient, what can be done to reduce them and what cannot be promised.

This article is about how to ask those questions clearly, not about recommending surgery for any particular person. The sections below follow the order in which the questions usually matter: what the operation is, how cancer control is discussed, how functional priorities are weighed, what alternatives exist, how catheter care and practical arrangements are handled, and what to confirm about follow-up before travelling.

One point applies throughout. A question that asks for a guarantee will get either a vague answer or a false one. A question that asks how the team reasons, what it reviews and what would change the plan is more likely to produce information you can actually use. That is the approach taken in each section below.

How to ask about cancer control without asking for a guarantee

Ask the surgical team for evidence-based estimates of benefits and risks relevant to your situation, including how much uncertainty remains. An estimate is not a promise of an individual outcome. Instead, ask how the team reviews the cancer before surgery: what staging information is available, whether the imaging and biopsy have been reviewed together, and what the pathology report after surgery will add.

A useful question is: "Based on my records, what is the goal of this operation, and what would change the plan?" This invites the team to explain the reasoning rather than offer reassurance. It also clarifies whether the aim is removal of the cancer with clear margins, or whether additional treatment may be discussed later.

Ask specifically how the team will review the removed prostate tissue. Pathology review after surgery informs whether further monitoring or treatment is needed. The timing and process for that review should be confirmed with the treating hospital, because arrangements differ between providers.

If the patient has already had a biopsy or imaging abroad, ask whether those materials need to be re-reviewed in China and what the team needs to see. Do not assume that records will be accepted without review; ask.

Functional priorities: continence and sexual function

Cancer control is not the only outcome that matters. Urinary continence and sexual function are common concerns, and the patient's own priorities should shape the discussion. Some patients place more weight on one than the other, and that is a legitimate part of the decision.

Ask the team how they approach preservation of function during surgery, what they can and cannot influence, and what recovery support is available afterward. Ask what any percentage estimate is based on, how it applies to your situation, and which factors could change it.

It is reasonable to ask whether the team has a structured approach to pelvic floor rehabilitation or continence support after surgery. The specific programme, timing and referral should come from the treating team, not from a general article.

If sexual function is a priority, ask whether nerve-sparing is being considered, what that means in this case, and what the trade-offs are. The answer depends on the cancer's location and extent, which only the treating team can assess.

Alternatives: what to ask before accepting surgery

Surgery is one option among several for prostate cancer. Others may include active surveillance, radiotherapy or other approaches, depending on the cancer's risk category and the patient's health. The treating team should be able to explain why one option is being recommended over another.

A direct question helps: "What are the alternatives for my cancer, and why is surgery being suggested rather than another approach?" Ask what the advantages and disadvantages of each option are in this specific case, not in general.

The answer to that question is where the decision actually gets made. If the team cannot explain why surgery is preferred over surveillance or radiotherapy for this cancer, that gap matters more than any general description of the operation. Ask what would change the recommendation: a different pathology result, a change in the patient's health, or a different priority on continence or sexual function.

A second useful question is what happens if the patient chooses an alternative first. Some men begin with surveillance and move to surgery later; others start with radiotherapy. Ask how the team would monitor the cancer under each route and what would trigger a change of plan. The treating team, not a coordination service, decides which route is clinically appropriate.

If the patient is considering care in China, ask whether the team can review records from abroad before any decision is made. A records-based opinion can clarify whether surgery is appropriate, but it does not replace an in-person assessment and does not guarantee that the hospital will accept the case.

Do not treat a remote opinion as a final plan. The treating hospital decides suitability after its own review.

It also helps to ask who else is involved in the decision. A urology team may discuss the case with radiation oncology or pathology colleagues before recommending one route. Ask whether that discussion has happened, and whether the patient's own priorities were part of it.

Finally, ask what the patient should do while deciding. If the cancer is not immediately threatening, there may be time to gather a second opinion or clarify records. If the team says the cancer needs prompt treatment, that advice should take priority over travel planning. Do not delay necessary local care to pursue an overseas enquiry.

Catheter care, hospital stay and practical arrangements

After radical prostatectomy, a urinary catheter is typically needed for a period. The exact duration, the care instructions and the plan for removal should come from the treating team. Ask who will explain catheter care, what to do if there is discomfort or a problem, and how follow-up is arranged after discharge.

Ask how long the hospital stay is expected to be and what the discharge process involves. These details vary between hospitals and between patients, so they should be confirmed in writing rather than assumed.

If the patient is travelling from abroad, ask how the hospital handles communication in English, whether an interpreter is available, and how prescriptions and follow-up appointments are arranged. These are practical questions for the hospital's international office, not clinical ones.

For planning purposes, it helps to ask for a written summary of what the hospital's estimate includes and what it does not. This is a question for the named provider, not a general assumption about how hospitals in China charge.

Follow-up and what to confirm before travelling

Follow-up after prostatectomy includes monitoring for cancer control and support for functional recovery. The schedule and the tests involved should be explained by the treating team. Ask what follow-up is recommended, where it can be done, and how results will be shared with the patient's doctors at home.

Before travelling to China for surgery, confirm the key points in writing: the proposed operation, the alternatives discussed, the plan for pathology review, the catheter and discharge plan, and the follow-up arrangements. If any of these is unclear, ask again before committing.

An initial enquiry to ChinaSpecialistCare is free. It can help clarify what records are needed and which questions to put to the hospital. It is not a diagnosis, not a promise of acceptance and not a substitute for the treating team's assessment. You can start with a brief summary through the enquiry form, email or WhatsApp.

The related procedure reference for robotic radical prostatectomy provides further background on the operation itself.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. BAUS: Robotic-assisted radical prostatectomy

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.